Andrew C. Jackson insider trades

Open-market stock purchases and sales by Andrew C. Jackson, Chief Financial Officer at Calidi Biotherapeutics, Inc, from SEC Form 4 filings since Jun 13, 2019.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -92%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • CLDI Calidi Biotherapeutics, Inc: 1 buy, last Sep 3, 2025
  • BTX Brooklyn ImmunoTherapeutics, Inc: other filings, last Jun 3, 2022
  • RMED Ra Medical Systems, Inc: 2 buys, 2 sales, last May 20, 2022

Get free alerts when Andrew C. Jackson files a new trade →